← Open Payments lookup

MEGAN ULE: Open Payments

NPI 1245926419 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,617 in 86 payments from 15 companies in 2025. Trend: 2023 $395 · 2024 $1,570 · 2025 $1,617

Food & beverage: $1,540Education: $77
CompanyPaymentsAmount
ABBVIE INC.48$634
Janssen Biotech, Inc.9$230
Ardelyx, Inc.10$212
Janssen Scientific Affairs, LLC1$141
Madrigal Pharmaceuticals4$104
Takeda Pharmaceuticals U.S.A., Inc.2$50
QOL Medical, LLC2$37
VIVUS LLC2$33
Aimmune Therapeutics, Inc.2$33
Ferring Pharmaceuticals Inc.1$32

Products named: TREMFYA, CREON, IBSRELA, LINZESS, REZDIFFRA, SKYRIZI, RINVOQ, ENTYVIO.

Industry payments across TX — which companies pay providers there.